Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-08-08
2006-08-08
Andres, Janet L. (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C530S350000, C530S399000, C435S252300, C435S320100, C536S023400
Reexamination Certificate
active
07087411
ABSTRACT:
Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF mini-traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.
REFERENCES:
patent: 5851999 (1998-12-01), Ullrich et al.
patent: 6011003 (2000-01-01), Charnock-Jones
patent: 6100071 (2000-08-01), Davis-Smyth et al.
patent: 6270993 (2001-08-01), Shibuya
patent: WO 97/44453 (1997-11-01), None
patent: WO 98/13071 (1998-02-01), None
Wells (Sep. 18, 1990) Biochemistry 29(37): 8509-8517.
Ngo et al. (Mar. 2, 1995) “The Protein Folding Problem and Tertiary Structure Prediction, Chapter 14: Computational Complexity Protein Structure Prediction, and the Levinthal Paradox” pp. 492-495.
Bork (2000) Genome Research 10:398-400.
Skolnick and Fetrow (2000) Trends in Biotech. 18(1):34-39.
Doerks et al. (Jun. 1998) Trends in Genetics 14(6): 248-250.
Smith and Zhang (Nov. 1997) Nature Biotechnology 15:1222-1223.
Brenner (Apr. 1999) Trends in Genetics 15(4): 132-133.
Bork and Bairoch (Oct. 1996) Trends in Genetics 12(10): 425-427.
Wang et al. (1999) Nuc Acids Res. 27: 4609-4618.
Kaufman et al (1999) Blood 94: 3178-3184.
Wigley et al. (1994) Reprod Fert Dev 6: 585-588.
Phillips, A., J Pharm Pharmacology 53: 1169-1174, 2001.
Ashkenazi et al, 1995. Methods: A companion to Methods in Enzymology. 8: 104-115.
Holash, J., et al., (2002) PNAS, 99(17):11393-11398.
Heidaran, M.A., et al., (1990) J. Biol. Chem. 265(31):18741-18744.
Cunningham, S.A., et al., (1997) Biochem. Biophys. Res. Comm. 231:596-599.
Fuh, G., et al., (1998). J. Biol. Chem. 273(18):11197-11204.
Wiesmann, C., et al., (1997) Cell, 91:695-704.
Barleon, B., et al., (1997) J. Biol. Chem. 272(16):10382-10388.
Davis-Smyth, T., et al., (1998) J. Biol. Chem. 273(6):3216-3222.
Daly Thomas J.
Fandl James P.
Papadopoulos Nicholas J.
Andres Janet L.
Gregg, Esq. Valeta
Howard Zachary
Regeneron Pharmaceuticals Inc.
LandOfFree
Fusion protein capable of binding VEGF does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fusion protein capable of binding VEGF, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fusion protein capable of binding VEGF will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3694569